Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antirheumatic Agents”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)UnknownNCT06306339
What this trial is testing

Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug)

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
ImmuneMed, Inc. 60
Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Large-scale testing (Phase 3)Study completedNCT01235507
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Testing effectiveness (Phase 2)Study completedNCT01597739
What this trial is testing

JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 96
Large-scale testing (Phase 3)Study completedNCT01721057
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 684
Large-scale testing (Phase 3)Active Not RecruitingNCT06641076
What this trial is testing

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 960
Post-approval studies (Phase 4)Study completedNCT00631514
What this trial is testing

Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Who this might be right for
Hypertension
University of Split 88
Post-approval studies (Phase 4)Study completedNCT00848354
What this trial is testing

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

Who this might be right for
Rheumatoid Arthritis
Pfizer 429
Large-scale testing (Phase 3)Study completedNCT01604343
What this trial is testing

CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 1,670
Post-approval studies (Phase 4)Study completedNCT02433184
What this trial is testing

Very Early Versus Delayed Etanercept in Patients With RA

Who this might be right for
Rheumatoid Arthritis
University of Leeds 120
Large-scale testing (Phase 3)WithdrawnNCT04483687
What this trial is testing

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy

Who this might be right for
Ankylosing Spondylitis
Gilead Sciences
Post-approval studies (Phase 4)UnknownNCT02765594
What this trial is testing

Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Peking Union Medical College Hospital 98
Large-scale testing (Phase 3)Study completedNCT02706951
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

Who this might be right for
Rheumatoid Arthritis
AbbVie 648
Post-approval studies (Phase 4)Study completedNCT01511003
What this trial is testing

A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 128
Very early researchStudy completedNCT00965666
What this trial is testing

Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia

Who this might be right for
Fanconi Anemia
Children's Hospital Medical Center, Cincinnati 3
Early research (Phase 1)Study completedNCT00902460
What this trial is testing

CP-690,550 and Midazolam Drug-Drug Interaction Study

Who this might be right for
Healthy Volunteer
Pfizer 25
Post-approval studies (Phase 4)Study completedNCT03762824
What this trial is testing

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease

Who this might be right for
Rheumatoid ArthritisSystemic LupusSjögren Syndrome+2 more
Region Skane 300
Large-scale testing (Phase 3)Study completedNCT01519791
What this trial is testing

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 880
Large-scale testing (Phase 3)WithdrawnNCT04483700
What this trial is testing

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy

Who this might be right for
Ankylosing Spondylitis
Gilead Sciences
Next Page